These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1133727)

  • 1. Nidation inhibition by simple ergoline derivatives.
    Rezábek K; Cassady JM; Floss HG
    J Pharm Sci; 1975 Jun; 64(6):1045-6. PubMed ID: 1133727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
    Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
    Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive ergolinepropionamides.
    Bernardi L; Bosisio G; Mantegani S; Sapini O; Temperilli A; Salvati P; di Salle E; Arcari G; Bianchi G
    Arzneimittelforschung; 1983; 33(8):1094-8. PubMed ID: 6685485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
    Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
    Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiulcer and antisecretory ergoline derivatives.
    Ruggieri D; Arrigoni C; Di Salle E; Temperilli A; Giudici D
    Farmaco; 1989 Jan; 44(1):39-50. PubMed ID: 2742720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.
    Flückiger E; Briner U; Clark B; Closse A; Enz A; Gull P; Hofmann A; Markstein R; Tolcsvai L; Wagner HR
    Experientia; 1988 May; 44(5):431-6. PubMed ID: 3371446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive ergoline derivatives.
    Mantegani S; Temperilli A; Traquandi G; Salvati P; Di Salle E; Lamberti E; Bonsignori A
    Drug Des Deliv; 1987 May; 1(4):313-23. PubMed ID: 3509340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antihypertensive activity of 2,4-dioxoimidazolidin-1-yl and perhydro-2,4-dioxopyrimidin-1-yl ergoline derivatives.
    Mantegani S; Brambilla E; Caccia C; Chiodini L; Ruggieri D; Lamberti E; Di Salle E; Salvati P
    Farmaco; 1998 Apr; 53(4):293-304. PubMed ID: 9658588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro and in vivo evaluation of dopaminergic ergoline derivatives.
    Mantegani S; Brambilla E; Caccia C; Di Salle E; Cervini MA; McArthur RA; Traquandi G; Varasi M
    Farmaco; 1998 Jan; 53(1):65-72. PubMed ID: 9543728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
    Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
    Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ergoline congeners as potential inhibitors of prolactin release. 2.
    Rusterholz DB; Barfknecht CF; Clemens JA
    J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergot alkaloids. Synthesis of 6-methyl-8-ergolenes as inhibitors of prolactin release.
    Li GS; Robinson JM; Floss HG; Cassady JM
    J Med Chem; 1975 Sep; 18(9):892-5. PubMed ID: 1159711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergolines as potential prolactin and mammary tumor inhibitors.
    Cassady JM; Floss HG
    Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigations on the mode of action of D-6-methyl-8-cyanomethylergoline in suppressing pregnancy in the mouse.
    Mantle PG; Finn CA
    J Reprod Fertil; 1971 Mar; 24(3):441-4. PubMed ID: 5548636
    [No Abstract]   [Full Text] [Related]  

  • 15. Ergoline congeners as potential inhibitors of prolactin release. 3. Derivatives of 3-phenylpiperidine.
    Rusterholz DB; Barfknecht CF; Clemens JA
    J Med Chem; 1977 Jan; 20(1):85-8. PubMed ID: 13217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
    Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
    Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prolactin secretion in rats with the ergoline derivative deprenon.
    Chlebounová J; Seda M; Fingerová H; Rezábek K
    Arzneimittelforschung; 1980; 30(6):956-8. PubMed ID: 7191272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
    Markó M
    Eur J Pharmacol; 1984 Jun; 101(3-4):263-6. PubMed ID: 6468500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergot alkaloids. Synthesis of 6-alkyl-8-ergolenes and 6-methyl-8-aminoergolines as potential prolactin inhibitors.
    Crider AM; Robinson JM; Floss HG; Cassady JM; Clemens JA
    J Med Chem; 1977 Nov; 20(11):1473-7. PubMed ID: 915908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergot alkaloids. New ergolines as selective dopaminergic stimulants.
    Stütz PL; Stadler PA; Vigouret JM; Jaton A
    J Med Chem; 1978 Aug; 21(8):754-7. PubMed ID: 567695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.